FindTrial
Sign In

Fluoxetine Hydrochloride

DRUG5 trials

Sponsors

Dr. Reddy's Laboratories Limited, Teva Pharmaceuticals USA, University Health Network, Toronto

Conditions

Brain DiseasesBrain InfarctionBrain IschemiaCentral Nervous System DiseasesCerebral InfarctionCerebrovascular AccidentCerebrovascular DisordersHealthy

Phase 1

Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 mg of Dr. Reddy's Under Fasting Condition
CompletedNCT01166100
Dr. Reddy's Laboratories LimitedHealthy
Start: 2006-02-28End: 2006-08-31Updated: 2010-07-21
Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg of Dr. Reddy's Under Fed Condition
CompletedNCT01166087
Dr. Reddy's Laboratories LimitedHealthy
Start: 2006-02-28End: 2006-09-30Updated: 2010-07-21
90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions
CompletedNCT01247272
Teva Pharmaceuticals USAHealthy
Start: 2001-05-31End: 2001-07-31Updated: 2011-02-21
90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions
CompletedNCT01247285
Teva Pharmaceuticals USAHealthy
Start: 2001-05-31End: 2001-07-31Updated: 2011-02-21

Phase 2

Fluoxetine Opens Window to Improve Motor Recovery After Stroke
CompletedNCT03448159
University Health Network, TorontoBrain Diseases, Brain Infarction, Brain Ischemia +7
Start: 2019-01-01End: 2022-09-30Updated: 2022-11-04